Drug intelligence / Profile preview

Shenzhu Jing Capsules

Development stage: Unknown
Lead developer: Jingxin Pharmaceutical
Administration: Oral

Overview

Shenzhu Jing Capsules (参竹精胶囊) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Zhejiang Jingxin Pharmaceutical. It is approved in China for the treatment of syndromes associated with Qi and Yin deficiency. The formulation is composed of several botanical extracts, including Ginseng (Panax ginseng), Polygonatum sibiricum (Huangjing), Lycium chinense (Gouqizi), Morus alba fruit (Sangshen), and Cuscuta chinensis seed (Tusizi). It is clinically indicated to tonify Qi and Yin, nourish the kidneys, and moisten the lungs, addressing symptoms such as dizziness, palpitations, insomnia, limb numbness, and weakness in the waist and knees.

Brand names: Shenzhu Jing Capsules参竹精胶囊
Other names: Shenzhujing Capsules

Beyond the preview

Go deeper on Shenzhu Jing Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenzhu Jing Capsules.

Explore the full profile